A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer.

Abstract	The epidermal growth factor receptor (EGFR) is overexpressed on the superficial layers of malignant urothelium and is suspected of playing a role in tumor progression. TP40 is a chimeric protein composed of transforming growth factor-alpha (TGF alpha) fused to a modified form of Pseudomonas exotoxin A (PE) that is selectively cytotoxic to EGFR-bearing cells and is currently undergoing clinical study for the intravesical therapy of bladder cancer. We constructed a recombinant toxin PE35/TGF alpha-KDEL as an improved agent for the local therapy of EGFR-bearing bladder cancer. PE35/TGF alpha-KDEL does not require intracellular proteolysis to generate a carboxyl-terminal fragment capable of reaching the target cell cytosol and contains a modified carboxyl-terminal sequence KDEL, that increases toxin activity. These features make PE35/TGF alpha-KDEL from 10- to 700-fold more potent than TP40 on four human bladder cancer cell lines. PE35/TGF alpha-KDEL may be a useful agent for treatment of EGFR-bearing cancers.
Authors	C P Theuer, D J FitzGerald, I Pastan
Journal	The Journal of urology (J Urol) Vol. 149 Issue 6 Pg. 1626-32 (Jun 1993) ISSN: 0022-5347 [Print] United States
PMID	8501821 (Publication Type: Journal Article)
Chemical References	Bacterial Toxins Exotoxins Immunotoxins Recombinant Fusion Proteins Recombinant Proteins Transforming Growth Factor alpha Virulence Factors transforming growth factor(alpha)-Pseudomonas exotoxin A (35) ADP Ribose Transferases Pseudomonas aeruginosa exotoxin A ErbB Receptors
Topics	ADP Ribose Transferases Bacterial Toxins (therapeutic use) Drug Design Drug Screening Assays, Antitumor ErbB Receptors (drug effects) Exotoxins (therapeutic use) Humans Immunotoxins (therapeutic use) In Vitro Techniques Pseudomonas aeruginosa Recombinant Fusion Proteins Recombinant Proteins (therapeutic use) Transforming Growth Factor alpha (therapeutic use) Urinary Bladder Neoplasms (chemistry, therapy) Virulence Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!